Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update

Go back to Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update
(NASDAQ: ACRS) Delayed: 5.78 -0.08 (1.37%)
Previous Close $5.86    52 Week High $33.88 
Open $5.82    52 Week Low $14.12 
Day High $5.86    P/E N/A 
Day Low $5.64    EPS $0.00 
Volume 666,269